Search results

Items from 1 to 20 out of 885 results

article

Issues and concerns in nanotech product development and its commercialization

Indu Pal Kaur, Vandita Kakkar, Parneet Kaur Deol, Monika Yadav, more

Journal of Controlled Release > 2014 > 193 > Complete > 51-62

The revolutionary and ubiquitous nature of nanotechnology has fetched it a considerable attention in the past few decades. Even though its enablement and application to various sectors including pharmaceutical drug development is increasing with the enormous government aided funding for nanotechnology-based products, however the parallel commercialization of these systems has not picked up a similar...

article

Media framing of sustainability: The case of British pharmaceutical companies (2000–2020)

Dejan N. Zec

Sustainable Development > 32 > 4 > 4001 - 4019

Corporate sustainability is a complex concept, creating ambiguity regarding what it means and entails in a given context. Especially in sectors such as the pharmaceutical industry, where there is little direct interaction between the company and its stakeholders, infomediaries such as the mass media play a pivotal role in framing corporate sustainability and providing social evaluations to the general...

article

Applications of electrophoresis for small enantiomeric drugs in real‐world samples: Recent trends and future perspectives

Imran Ali, Miryam Perrucci, Luigi Ciriolo, Cristian D'Ovidio, more

ELECTROPHORESIS > 45 > 1-2 > 55 - 68

Separation and identification of chiral molecules is a topic widely discussed in the literature and of fundamental importance, especially in the pharmaceutical and food fields, both from industrial and laboratory points of view. Several techniques are used to carry out these analyses, but high‐performance liquid chromatography is often the “gold standard.” The high costs of chiral columns, necessary...

article

How Managers Respond to Paradoxical Control‐Trust Dynamics in Interorganizational Relationships over Time: A Constitutive Approach

Jane Bjørn Vedel, Joana Geraldi

Journal of Management Studies > 60 > 8 > 2060 - 2090

Control‐trust dynamics are fundamental to organizational life, but managers struggle to balance them because these dynamics draw on opposing mechanisms. Past research has mainly assumed that substitution and complementarity constitute key control‐trust dynamics, which has limited scholars' understanding of why these dynamics are difficult to balance and how managers deal with them over time. We explore...

article

Bad medicine: Litigation, competition, and the marketing of prescription opioids

David Tan, Nicole V. West

Strategic Management Journal > 44 > 11 > 2658 - 2687

Research Abstract How do competitors respond when a firm experiences an increased threat of penalties for questionable business activities? While conventional wisdom suggests that competitors will attempt to avoid similar activities, we draw attention to a countervailing incentive. If an increased threat of penalties induces one firm to reduce its engagement in an activity, competitors in an industry...

article

Characterization of industry relationships in oncology

Rebecca A. Harrison, Nazanin K. Majd, Margaret O. Johnson, Diana L. Urbauer, more

Cancer > 129 > 18 > 2848 - 2855

Background Collaborative relationships between academic oncology and industry (pharmaceutical, biotechnology, “omic,” and medical device companies) are essential for therapeutic development in oncology; however, limited research on engagement in and perceptions of these relationships has been done. Methods Survey questions were developed to evaluate relationships between academic oncology and industry...

article

Patent pools and innovation‐based approach in global healthcare crisis

Sherin Priyan, Gouri Gargate

The Journal of World Intellectual Property > 26 > 2 > 117 - 141

During the COVID 2019 pandemic, the healthcare sector faced major jurisprudential questions about the intellectual property system. During this period, the world was in the midst of a healthcare crisis, wherein the debate between the reward for innovation versus accessibility to all at equitable rates have become intense. In a such challenging scenario, the scientific community were dedicated toward...

article

“Not a box of nuts and bolts”: Distribution channels for specialty drugs

Liang Xu, Vidya Mani, Hui Zhao

Production and Operations Management > 32 > 7 > 2283 - 2303

One of the most important trends in the pharmaceutical industry is the rapid growth of specialty drugs. Specialty drugs, mostly bio based, tend to be high risk, high priced, and more regulated than traditional drugs, resulting in unprecedented challenges in distribution. Such challenges lead to the emergence of specialty distributors (SDs), which, compared with traditional wholesalers (WSs), represent...

article

Efforts to Replace Methylene Chloride in Pharmaceutical Process Chemistry

Ruchika Yogesh, Noopur Srivastava, Baban Mohan Mulik

Macromolecular Symposia > 407 > 1 > n/a - n/a

Methylene chloride (MC) or dichloromethane is a halogenated organic solvent of choice used in many chemical industries such as pharmaceutical, insecticide, paint, and polymer industries. Several health hazards associated with the use of MC are known to us through available literature. MC is reported to be a potential neurotoxic, cardiotoxic, cancer‐causing, and tissue‐damaging agent. Inhalation and...

article

Ujawnienia informacji o kapitale relacyjnym na przykładzie spółek branży lekowej notowanych na GPW w Warszawie

Krzysztof Mataczyna

Studia i Prace Kolegium Zarządzania i Finansów > 2023 > 190 > 75-95

Artykuł stanowi podsumowanie badania sprawozdań finansowych i sprawozdań z działalności, sporządzanych za lata 2017–2021 przez przedsiębiorstwa branży lekowej notowane na GPW w Warszawie w odniesieniu do ujawniania informacji o kapitale relacyjnym. Celem artykułu jest wykazanie zróżnicowania ujawnień informacji w tym obszarze oraz potrzeby dalszej standaryzacji sprawozdawczości niefinansowej. Artykuł...

article

“It Works by Activating Very Basic Instincts […]”: Medical Students’ Opinions about the Benefits and Risks of the Pharmaceutical Industry’s Marketing Efforts Aimed at Medical Doctors

Marta Makowska

Przegląd Socjologii Jakościowej > 2023 > 19 > 3 > 220-241

Cooperation between the pharmaceutical industry and medical doctors is both necessary and inevitable. As part of the medical community, medical students are likely to have developed specific views as to its benefits and risks. The article is part of a series of articles presenting selected results of nine focus group interviews from three cities (Warsaw, Kraków, and Gdańsk). The study used social...

article

The impact of firm-based organizational citizenship behavior on continuance and normative commitment among pharmaceutical executives: An SEM approach

Theophilus Ehidiamen Oamen

Journal of Economics and Management > 2023 > 45 > 47-67

Aim/purpose – The study was based on social exchange theory and addressed the effects of firm-based organizational citizenship behavior (OCB) on normative and continuance organizational commitment (OC). Multigroup behavioral differences among pharmaceutical executives were also evaluated. Design/methodology/approach – This study employed an empirical, explanatory cross-sectional study with online...

article

The additive value of patch testing non‐commercial test substances and patients' own products in a clinic of occupational dermatology

Kristiina Aalto‐Korte, Maria Pesonen

Contact Dermatitis > 88 > 1 > 27 - 34

Background Commercial patch test substances do not cover all occupational contact allergens. Workplace materials and in‐house test substances are tested to complement the investigation of occupational skin disease (OSD). Objectives To quantify the additional value of testing workplace materials and non‐commercial in‐house test substances in the diagnosis of OSD. Materials and Methods Patients...

article

The challenge of institutionalised complicity: Researching the pharmaceutical industry in the era of impact and engagement

Paul A. Martin

Sociology of Health & Illness > 44 > S1 > 158 - 178

The pharmaceutical industry plays a central role in the production of the drugs we use to treat most illnesses. It is immensely powerful and has received sustained attention from sociologists of health and illness, who have provided a critique of its influence and sometimes unethical behaviour. However, in recent years, funders are increasingly expecting researchers to engage and collaborate with...

article

The Potential of Industrial Agglomeration to Promote Pharmaceutical Innovation: Analysis of China's “Medicine Valley” Construction Upsurge

Jianting Fan, Fusen Zhao, Yuhao Zhao

China & World Economy > 30 > 6 > 86 - 112

This paper reports the innovation effect of pharmaceutical industry agglomeration from the perspective of patterns of agglomeration and innovation, by using registration application data for innovative and generic drugs as indicators of pharmaceutical innovation. First, the distribution of the pharmaceutical industry in China is characterized by high agglomeration and low innovation. Second, no significant...

article

Ambidexterity's influence on export strategy development—The case of the Indian pharmaceutical industry

Ashutosh Kolte, Giuseppe Festa, Matteo Rossi, Alkis Thrassou, more

Thunderbird International Business Review > 64 > 5 > 465 - 476

This study investigates the influence that business ambidexterity of the Indian pharmaceutical industry can exert on exports, after the evolution from producer—often with the support of foreign direct investments (FDIs)—to researcher. The growth rate of the sector has changed pace with the introduction of new rules regarding patents, impelling pharma enterprises to invest in research and development...

article

Related and unrelated product diversification and collaboration strategies: Comparison between the pharmaceutical and biopharmaceutical industries

Keungoui Kim, Junmin Lee, Junseok Hwang, Eungdo Kim

Journal of Product Innovation Management > 39 > 4 > 559 - 580

In pharmaceutical and biopharmaceutical industries, developing and commercializing products require great investments and intensive clinical trials. With regard to managing the risk and uncertainty of such product development, especially given the low success rates, product diversification and collaboration strategies can be instrumental for firms. Especially, the differences in product development...

article

The Main Trends and Challenges in The Development of the Different Industries During The COVID-19 Pandemic

Alexey I. Tikhonov, Andrey A. Sazonov, Vyacheslav M. Kraev, Irina Kuzmina-Merlino

Foundations of Computing and Decision Sciences > 2022 > Vol. 47, No. 2 > 209--231

The purpose of the research in this article is to investigate the main trends in the development of the different industries during the COVID-19 pandemic, to identify the main problems facing the different industries in the context of the global crisis, as well as to form the basic concepts necessary for a real recovery of the global industry. The authors identify the main problems facing the aviation...

article

Degree assortativity in collaboration networks and invention performance

Rajat Khanna, Isin Guler

Strategic Management Journal > 43 > 7 > 1402 - 1430

Research Summary We investigate the implications of the degree assortativity of intra‐firm networks for firms' innovation performance. We argue that prevalent patterns of collaborative relationships between organizational members can lead to variations in the levels of degree assortativity in intra‐firm networks, ranging from disassortative structures (highly central members connect with peripheral...

article

Making pharmaceutical companies report what matters about innovation

Adam Cohen, Rebecca Ultee, Glenn Veldhoven

British Journal of Clinical Pharmacology > 88 > 6 > 2583 - 2587

There is a lack of transparency about the cost of innovation of the pharmaceutical industry even though these costs are claimed to be the major driver for high prices for medicines. This is reflected by annual reports of the major pharmaceutical firms that contain a low number of pages on innovation and its detailed costs in comparison with pages about remuneration of executives where the detail...

Publication date

Last 3 months (1)
Last year (4)
Last 3 years (28)

Close

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

From:

To:
Set your own date range

Content availability

Available (782)
None (103)

Publication type

article (580)
book (305)

Publication language

English (783)
Polish (96)
German (11)
French (3)
Ukrainian (2)
Russian (1)
Spanish (1)

Keywords

PHARMACEUTICAL INDUSTRY (885)
DRUGS (98)
PRZEMYSŁ FARMACEUTYCZNY (72)
PHARMACEUTICALS (65)
INDUSTRIES (38)
BIOTECHNOLOGY (31)
COMPANIES (29)
CLINICAL TRIALS (27)
DATA MINING (26)
INNOVATION (26)
PRODUCTION ENGINEERING COMPUTING (26)
FOOD INDUSTRY (24)
SUPPLY CHAIN MANAGEMENT (24)
CONFLICT OF INTEREST (23)
BIOLOGICAL SYSTEM MODELING (22)
CHEMICAL INDUSTRY (22)
PROCESS CONTROL (22)
RADIOFREQUENCY IDENTIFICATION (22)
DRUG DEVELOPMENT (21)
DRUG DISCOVERY (21)
PRODUCTION (21)
SUPPLY CHAINS (21)
MONITORING (20)
QUALITY CONTROL (18)
ETHICS (16)
INNOVATION MANAGEMENT (16)
PATENTS (16)
MATHEMATICAL MODEL (15)
RESEARCH AND DEVELOPMENT (15)
LOGISTICS (14)
MEDICINE (14)
RFID (14)
TECHNOLOGICAL INNOVATION (14)
HEALTH CARE (13)
OPTIMIZATION (13)
PACKAGING (13)
COSMETIC INDUSTRY (12)
DECISION MAKING (11)
ELECTRONIC COMMERCE (11)
FERMENTATION (11)
INDEXES (11)
MARKETING (11)
MARKETING AND SALES (11)
PHARMACEUTICAL TECHNOLOGY (11)
PROTEINS (11)
PRZEMYSŁ KOSMETYCZNY (11)
SAFETY (11)
SOFTWARE (11)
FOOD PROCESSING INDUSTRY (10)
HOSPITALS (10)
INFORMATION SYSTEMS (10)
INSPECTION (10)
MEDICAL EDUCATION (10)
ORGANISATIONAL ASPECTS (10)
PHARMACEUTICAL MARKET (10)
PROCESS MONITORING (10)
R&D (10)
SUPPORT VECTOR MACHINES (10)
TRAINING (10)
WASTEWATER TREATMENT (10)
BATCH PROCESSING (INDUSTRIAL) (9)
CHEMICALS (9)
COMPOUNDS (9)
DISCLOSURE (9)
PHARMACEUTICAL SUPPLY CHAIN (9)
PRZEMYSL FARMACEUTYCZNY (9)
STRATEGIC PLANNING (9)
ARTIFICIAL NEURAL NETWORKS (8)
BIOLOGY (8)
BIOTECHNOLOGY INDUSTRY (8)
CHINA (8)
DISEASES (8)
DRUG (8)
ECONOMICS (8)
INDIA (8)
INTERNET (8)
INVESTMENT (8)
LEARNING (ARTIFICIAL INTELLIGENCE) (8)
MOLECULAR BIOPHYSICS (8)
ONTOLOGIES (ARTIFICIAL INTELLIGENCE) (8)
ORGANIC COMPOUNDS (8)
PHARMAZEUTISCHE INDUSTRIE (8)
PLANNING (8)
PRODUCTIVITY (8)
PROFITABILITY (8)
REGULATION (8)
RISK MANAGEMENT (8)
BIOLOGY COMPUTING (7)
CHROMATOGRAPHY (7)
COLLABORATION (7)
COMPUTER VISION (7)
CORRELATION (7)
DATA MODELS (7)
FDA (7)
GENETIC ALGORITHMS (7)
GOVERNMENT (7)
INFORMATION TECHNOLOGY (7)
KERNEL (7)
LAW (7)
MACHINE LEARNING (7)
more

Data set

ieee (304)
Elsevier (205)
Springer (149)
Wiley (91)
BazTech (67)
Agro (32)
CEJSH (31)
PSJD (6)

INFONA - science communication portal

Search results

Issues and concerns in nanotech product development and its commercialization

Media framing of sustainability: The case of British pharmaceutical companies (2000–2020)

Applications of electrophoresis for small enantiomeric drugs in real‐world samples: Recent trends and future perspectives

How Managers Respond to Paradoxical Control‐Trust Dynamics in Interorganizational Relationships over Time: A Constitutive Approach

Bad medicine: Litigation, competition, and the marketing of prescription opioids

Characterization of industry relationships in oncology

Patent pools and innovation‐based approach in global healthcare crisis

“Not a box of nuts and bolts”: Distribution channels for specialty drugs

Efforts to Replace Methylene Chloride in Pharmaceutical Process Chemistry

Ujawnienia informacji o kapitale relacyjnym na przykładzie spółek branży lekowej notowanych na GPW w Warszawie

“It Works by Activating Very Basic Instincts […]”: Medical Students’ Opinions about the Benefits and Risks of the Pharmaceutical Industry’s Marketing Efforts Aimed at Medical Doctors

The impact of firm-based organizational citizenship behavior on continuance and normative commitment among pharmaceutical executives: An SEM approach

The additive value of patch testing non‐commercial test substances and patients' own products in a clinic of occupational dermatology

The challenge of institutionalised complicity: Researching the pharmaceutical industry in the era of impact and engagement

The Potential of Industrial Agglomeration to Promote Pharmaceutical Innovation: Analysis of China's “Medicine Valley” Construction Upsurge

Ambidexterity's influence on export strategy development—The case of the Indian pharmaceutical industry

Related and unrelated product diversification and collaboration strategies: Comparison between the pharmaceutical and biopharmaceutical industries

The Main Trends and Challenges in The Development of the Different Industries During The COVID-19 Pandemic

Degree assortativity in collaboration networks and invention performance

Making pharmaceutical companies report what matters about innovation

Filter options

Publication date

Content availability

Publication type

Publication language

Keywords

Data set

INFONA - science communication portal

Search results

Add recipient

Sending message cancelled

Are you sure you want to cancel sending this message?

Send message

Filter options

Publication date

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

Content availability

Publication type

Publication language

Keywords

Data set

Reporting an error / abuse

Sending the report failed

Accessibility options